# TI Sigma Systematic Review: Contributions to Business & Engineering

**Living document — continuously updated as new results, URBs, and applied developments arrive.**
**Target audience:** Engineers, product managers, investors, and applied researchers evaluating TI Sigma's practical and commercial contributions.
**Last updated:** 2026-05-04
**Maintainer:** Autonomous Research Agent (on behalf of Brandon Charles Emerick)

---

## 1. Scope

This review covers TI Sigma's contributions to business, engineering, and applied technology: market analysis systems, biometric integration platforms, API-licensable engines, measurement units, computational architectures, and product/service concepts. "Business & Engineering" here means: commercially viable, operationally deployable, or engineering-novel.

---

## 2. Inventory of Business & Engineering Contributions

### 2.1 Tralse-Joule (TJ) — Unit of Intentionality

- **What it is:** A quantitative unit measuring intentional work. TJ = τ(s) × δ(MR), where τ is Tralseness (how much productive ambiguity the system processes) and δ(MR) is the depth of Myrion Resolution achieved (URB #650).
- **Engineering significance:** TJ provides a measurable output metric for cognitive systems, human-computer interaction, and AI agents. A session producing higher TJ output processed more ambiguity at greater depth.
- **Commercial potential:** TJ could serve as a billing unit for AI consultation services ("Your session produced 14.7 TJ of resolution") or as a performance metric for knowledge workers.
- **Current status:** Defined formally; not yet integrated into a billing or metrics system.

### 2.2 Grand Stock Algorithm (GSA v2)

- **What it is:** A stock market analysis and paper-trading system applying the TI Framework to financial markets.
- **Architecture:** Multi-signal pipeline integrating sentiment analysis, technical indicators, weather correlations, and TI Sigma's Tralse-weighted analysis.
- **Integration:** Alpaca for paper trading, Alpha Vantage for market data, PostgreSQL for signal storage, daily scheduler for automated signal generation.
- **Current status:** Paper trading active via `gsa_daily_scheduler` workflow. Performance logging to `gsa_paper_trades`, `gsa_performance_log`, and `gsa_portfolio_snapshots` database tables.
- **Commercial potential:** If GSA v2 demonstrates consistent alpha (returns above benchmark), the algorithm could be licensed or deployed as a managed strategy.

### 2.3 TI Framework for Prediction Markets

- **What it is:** Application of Tralse-weighted analysis to prediction markets (Kalshi, Collective2).
- **Integration:** Kalshi API key configured; Collective2 API key and system ID configured.
- **Current status:** Infrastructure connected; systematic trading strategy not yet deployed.
- **Commercial potential:** Prediction markets are a growing asset class. A TI-Sigma-informed strategy that outperforms naive probability estimation would be commercially valuable.

### 2.4 Mood Amplifier Hub

- **What it is:** A real-time biometric integration platform providing PSI score, GILE score, and chakra/meridian mapping.
- **Architecture:** Multi-channel input (Oura, Polar H10, Muse, Pulsoid, Mendi, Biowell), composite scoring engine, real-time dashboard.
- **Engineering features:**
  - Mycelial GM-Node Architecture for distributed intelligence
  - Focus Amplifier System (7-mode biometric-driven focus optimization)
  - Mycelial Resonance Engine (MRE) v2 + L4 + L5 (closed-loop ambient brain-entrainment)
  - SSVEP visual overlay for real-time brainwave entrainment
- **Current status:** Architecture designed and partially implemented. Real-time data pipelines scaffolded; awaiting multi-channel live data.
- **Commercial potential:** The Mood Amplifier could be productized as a consumer wellness platform (B2C) or licensed as an API for enterprise wellness programs (B2B).

### 2.5 GILE-I Engine (API-Licensable Core)

- **What it is:** The core AI engine planned for API licensing to generate recurring revenue.
- **Strategic vision:** Expose TI Sigma's scoring, analysis, and prediction capabilities as a REST API. Revenue model: per-call pricing + monthly subscription tiers.
- **Components:** GILE score computation, Tralse-weighted analysis, MR protocol execution, PD prediction, biometric integration.
- **Current status:** Individual components exist in the codebase; unified API wrapper not yet built.
- **Revenue target:** Budget constraint is <$50 total development cost, implying lean infrastructure using free tiers (Replit, PostgreSQL, free API quotas).

### 2.6 TI Sigma Computing Language (TICL)

- **What it is:** A domain-specific language for expressing computations in TI Sigma's 5-valued logic.
- **Engineering features:** Ternary computation primitives, Quantum Collapse Simulator, 5-valued logic operators.
- **Current status:** Language specification drafted; interpreter not yet implemented.
- **Commercial potential:** TICL could be positioned as a niche programming language for consciousness-informed AI development, similar to how Wolfram Language serves computational mathematics.

### 2.7 Biometric Integration Engineering

- **What it is:** The engineering work required to connect diverse biometric devices to a unified pipeline.
- **Devices integrated (varying stages):**
  - Oura Ring: API harvest implemented, 30-day data pulled
  - Polar H10: BLE visible (MAC: C0:4B:CC:EA:E1:54), database schema ready, streaming not yet implemented
  - Muse: Database schema ready, no data pipeline built
  - Pulsoid/ESP32: 24,372 samples collected, highest-volume channel
  - Mendi: BLE scan successful (MAC: F8:1C:96:82:73:AD), GATT discovery pending
  - Biowell: One legacy session (2025-11-25), appointment pending for new capture
- **Engineering challenges:** BLE reverse-engineering (Mendi), cross-device time synchronization, real-time streaming architecture, data quality validation.

### 2.8 Research-to-Video Pipeline (YouTube Studio)

- **What it is:** A Streamlit UI for converting research papers and analyses into video content.
- **Current status:** UI implemented; video generation pipeline scaffolded.
- **Commercial potential:** If TI Sigma generates publishable research, automated video summaries could drive YouTube channel growth and audience building.

### 2.9 Papers Browser & TI Sigma Atlas

- **What it is:** A Streamlit-based document management system for browsing, categorizing, and downloading research papers and assets.
- **Features:** URB cross-reference graph, topic-prefix categorization, TI Sigma Atlas (8-field taxonomy with cross-listing), Index & Acronyms tab (auto-extracted glossary), download buttons, timeline view.
- **Engineering significance:** Demonstrates that TI Sigma's research corpus is systematically organized and navigable — a prerequisite for any knowledge-management product.

### 2.10 Zenodo DOI Publication Pipeline

- **What it is:** Infrastructure for publishing research papers with permanent DOIs on Zenodo.
- **Current status:** Zenodo token configured; batch upload system built; DOI publication currently HELD per Brandon's directive.
- **Commercial potential:** DOI-published papers establish priority and credibility for the TI Sigma framework in academic and investor contexts.

---

## 3. SWOT Analysis

### Strengths

1. **Full-stack implementation.** TI Sigma is not just theory — it has running code, active workflows (GSA daily scheduler, discovery scheduler, TI website, hypercomputer), a PostgreSQL database, and real biometric data (24K+ Pulsoid samples, Oura harvest).
2. **Low-cost development.** The entire platform is built within a <$50 budget constraint using free tiers (Replit, PostgreSQL, free API quotas). This demonstrates capital efficiency and validates the lean-startup model.
3. **Multi-revenue-stream potential.** API licensing (GILE-I engine), managed trading (GSA v2), consumer wellness (Mood Amplifier), prediction markets (Kalshi/C2), and content (YouTube pipeline) represent diversified revenue opportunities.
4. **Tralse-Joule is a novel metric.** No existing system quantifies "intentional work" as a measurable unit. If TJ gains adoption, it could become a standard metric in AI/human-performance contexts.
5. **Biometric device breadth.** Integration with 6 distinct biometric devices (Oura, Polar, Muse, Pulsoid, Mendi, Biowell) demonstrates engineering ambition and convergent-validation methodology.

### Weaknesses

1. **No revenue generated.** As of 2026-05-04, no commercial transactions have occurred. All systems are in development/paper-trading mode.
2. **Single developer.** The entire platform depends on one person (Brandon) and one autonomous agent. Bus factor = 1.
3. **GSA v2 performance unvalidated.** Paper trading results have not been benchmarked against simple baselines (S&P 500 buy-and-hold, equal-weight portfolio). Without this comparison, alpha claims are unsupported.
4. **Biometric pipeline fragmentation.** 6 devices at varying integration stages means no single channel has a complete end-to-end pipeline. The ESP32/Pulsoid channel (24K samples) is the only one producing volume data.
5. **TICL is vaporware.** The computing language is specified but has no interpreter, no compiler, no IDE, and no users. It is a liability on the product roadmap until implementation begins.

### Opportunities

1. **Polar H10 direct streaming.** BLE scan confirmed the H10 is visible. Implementing bleak-based RR-interval streaming would provide clinical-grade HRV data without depending on the Oura API.
2. **Prediction market entry.** Kalshi and Collective2 APIs are configured. Deploying a systematic TI-Sigma-informed strategy on prediction markets could generate revenue with minimal capital.
3. **Open-source GILE library.** Publishing a Python `gile` package on PyPI with GILE scoring, TJ measurement, and 5-valued logic operators could drive adoption and community building at zero cost.
4. **Wellness API partnerships.** The Mood Amplifier's multi-channel architecture could be licensed to corporate wellness providers (e.g., Calm, Headspace, Whoop) as a differentiated scoring engine.
5. **Grant funding.** The pre-registered experimental protocols (URB #826, #828) with SHA-256 tamper-evidence are grant-application-ready. Small grants (PSI, Templeton, BIAL Foundation) could fund equipment and participant recruitment.

### Threats

1. **Market timing.** If GSA v2 launches during a market regime change (e.g., transition from trending to mean-reverting markets), initial performance may be unrepresentative.
2. **Regulatory risk.** If the GILE-I engine makes health-related claims (mood improvement, focus optimization), it may trigger FDA or FTC scrutiny.
3. **Competitive landscape.** Whoop, Oura, and Neurable already offer biometric integration platforms with larger teams and established user bases. TI Sigma's differentiation must be the GILE/Tralse scoring layer, not the hardware integration.
4. **API pricing pressure.** Cloud AI APIs (OpenAI, Anthropic, Google) are rapidly commoditizing. A GILE-I API must demonstrate value beyond what a general-purpose LLM can provide.
5. **Budget constraint is double-edged.** While capital efficiency is a strength, <$50 total budget means no paid marketing, no paid user acquisition, no paid testing infrastructure. Growth must be entirely organic or grant-funded.

---

## 4. Key Cross-References

| System / Document | Status |
|---|---|
| GSA v2 | Paper trading active |
| Kalshi integration | API connected, strategy pending |
| Collective2 integration | API connected, strategy pending |
| Mood Amplifier Hub | Architecture designed, data pending |
| GILE-I Engine | Components exist, API wrapper pending |
| TICL | Specification drafted, no implementation |
| YouTube Studio pipeline | UI implemented |
| Papers Browser + TI Sigma Atlas | Live, fully functional |
| Zenodo pipeline | Built, publication HELD |

---

## 5. Verdict for Technical Audience

TI Sigma's business and engineering portfolio is **broad, capital-efficient, and systematically architected, but pre-revenue and pre-validation.** The full-stack implementation (running workflows, live database, real biometric data, active paper trading) demonstrates engineering competence. The <$50 budget constraint is impressive as a proof of lean development.

The critical gap is **commercial validation.** No revenue has been generated, no GSA performance has been benchmarked, and no API has been exposed to external users. The next 90 days should prioritize: (1) GSA v2 performance reporting vs. benchmark, (2) one paying API customer or prediction-market deployment, and (3) completing at least one biometric pipeline end-to-end.

**The strongest near-term commercial opportunity** is prediction markets (Kalshi + Collective2). Infrastructure is connected, capital requirements are low, and results are immediately measurable. If TI Sigma's Tralse-weighted analysis produces positive expected value on prediction markets, it validates the commercial thesis without requiring hardware, partnerships, or regulatory approval.
